MENU

Why these 4 ASX shares have dropped lower today

It has been a disappointing day of trade for the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO). In afternoon trade the benchmark index is down almost 0.4% to 6,251 points.

Four shares that have fallen more than most today are listed below. Here’s why they have dropped lower:

The Eclipx Group Ltd (ASX: ECX) share price has plunged 45% lower to $1.68 after a surprise profit downgrade. Eclipx expects to report FY 2018 NPATA of between $77 million and $80 million, up between 13% and 17% on FY 2017, but a downgrade from previous guidance for growth between 27% and 30%. The underperformance of the Grays eCommerce business it acquired last year has been blamed for the poor result.

The Galaxy Resources Limited (ASX: GXY) share price has given back some of yesterday’s gains and is down almost 4% to $2.73. Almost all of Australia’s lithium miners have taken a tumble today after making strong gains on Monday. Opinion remains divided on the lithium miners and future prices of the battery-making ingredient.

The Neuren Pharmaceuticals Ltd (ASX: NEU) share price has sunk a massive 43% to $1.52 despite announcing an exclusive North American license agreement with ACADIA Pharmaceuticals for the development and commercialisation of trofinetide for Rett syndrome and other indications. Neuren will receive an upfront fee of US$10 million plus potential milestones of up to US$455 million and tiered, escalating, double-digit percentage royalties on net sales of trofinetide. The market appears to have been expecting a better deal.

The Ramsay Health Care Limited (ASX: RHC) share price has fallen 4% to $54.70 despite there being no news out of the private hospital operator. Short interest in Ramsay’s shares has been rising quickly in recent weeks and may be behind today’s decline. I would stay clear of Ramsay until there is a major improvement in trading conditions and its overall performance.

OUR #1 dividend pick to grow your wealth over the new financial year is revealed for FREE here!

Financial year 2018 is here and The Motley Fool’s dividend detective Andrew Page has revealed his must buy dividend share to grow your wealth in 2018.

You might not know this market leader's name, but it's rapidly expanding into a highly profitable niche market here in Australia. Even better, the shares boast a strong, fully franked dividend that should balloon in the years to come. In other words, we're looking at the holy grail of incredible long-term growth potential AND income you can watch accruing in your account in real time!

Simply click here to grab your FREE copy of this up-to-the-minute research report on our #1 dividend share recommendation now.

Motley Fool contributor James Mickleboro owns shares of Galaxy Resources Limited. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…

Including:

The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!